Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Vaccine

Hantavirus outbreak: Scientists ran out of funds while developing a vaccine, report says

A Hantavirus outbreak linked to the MV Hondius cruise ship has tragically claimed three lives this year, with 11 cases reported. While infections are rare, this outbreak highlights the urgent need for a vaccine, with research stalled by funding issues. International efforts are underway to manage the current situation, focusing…

The Times of India

Hantavirus scientists were close to vaccine but ran out of money

Scientists in Chile developed antibodies that successfully neutralised the deadly Andes hantavirus in lab and animal studies, raising hopes for a treatment against the rare virus that can spread between people. But the project stalled before human trials due to lack of funding and the Covid-19 pandemic.

The Economic Times

Valneva Q1 Earnings Call Highlights

Valneva (NASDAQ:VALN) reported lower first-quarter revenue and a wider loss for 2026, while management said the company is focused on conserving cash as it awaits the next regulatory steps for its Lyme disease vaccine candidate being developed with Pfizer. Chief Executive Officer Thomas Lingelbach

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Staged claims and Israeli hoaxes: Debunking viral conspiracy theories about hantavirus

Misinformation about hantavirus has run rampant on social media, with online users reviving viral COVID-19 theories to spread fake news about the outbreak.

Euronews

Is there a hantavirus vaccine? Scientists race to develop one for new strain

A deadly hantavirus outbreak on a cruise ship has raised fears over emerging viruses with no cure or vaccine. The UK government had already commissioned researchers to develop what could become the world’s first hantavirus vaccine

Euronews

Urgent care clinics, medicines and vaccines: what the budget means for Australians’ health

Health was at the heart of last year’s budget. Last night, tax and housing took centre stage, and there were few surprises in health.

The Conversation

Capricor Therapeutics Q1 Earnings Call Highlights

Capricor Therapeutics (NASDAQ:CAPR) said its Duchenne muscular dystrophy therapy candidate deramiocel remains under active FDA review, while the company is preparing to commercialize the product itself amid a legal dispute with distribution partner NS Pharma and parent company Nippon Shinyaku. On t

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

The White House told RFK Jr to tone down his statements questioning vaccines. That hasn’t stopped him behind the scenes

The reported review concerns Kennedy’s long-held skepticism of mainstream vaccine science

The Independent UK

Is There A Cure For Hantavirus Infection? 'Breathed In' Virus Kills 38% Of Patients, Scientists Race For Vaccine

A deadly cruise ship outbreak of the Andes strain has revived global interest in a long‑delayed hantavirus cure, as scientists warn that early hospital care can make the difference between survival and a 38% fatality risk.

International Business Times UK

Free meningococcal jabs for some but 'lottery' persists

A fourth Australian jurisdiction will provide free jabs to some teens for a rare but life-threatening disease as the push for national coverage marches on.

AAP

The Guardian view on the WHO pandemic treaty: the west’s fantasy negotiations have put the world at risk

Editorial: After five years of deliberation the global south has forced the question that defined the Covid crisis: who will get the vaccines?

The Guardian - UK

‘The FDA is a complete mess’: Trump makes fate of agency chief unclear as public trust plummets

Food and Drug Administration commissioner’s decisions have hurt staff morale and put his job in crosshairs

The Guardian - US

Trump's Health Bureaucrats Are Undermining Confidence in Vaccines

From spiked CDC reports to blocked FDA studies, officials sidelined evidence showing vaccines are safe and effective.

Reason

FDA's new playbook: Lots of media announcements but not much rulemaking

Health Secretary Robert F. Kennedy Jr. and other health officials have repeatedly announced major changes before any new rules have been drafted

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

‘People should be talking about it’: moves to curtail vaccine information obscures important science, doctors say

Quashed studies, halted publications and canceled research threaten damage to public health, critics say

International Business Times

HHS Studies That Found Covid, Shingles Vaccines Safe And Effective Pulled From Scientific Journals

The Food and Drug Administration (FDA) has withdrawn studies that suggested COVID-19 and shingles vaccines were safe and effective.

The Independent UK

Trump’s third surgeon general pick is deleting old posts critical of president’s agenda and fitness

Dr Nicole Saphier, a radiologist, author and Fox News contributor, scrubs X account of posts questioning administration’s handling of issues related to autism and vaccines

Latin Times

Experts Criticize F.D.A. Move to Withhold Studies on Vaccine Safety: 'A Pretty Active Act of Sabotage'

Blocked publications on COVID and shingles vaccines come amid broader changes to federal policy under Health Secretary Robert F. Kennedy Jr., a longtime vaccine critic

Get all your
news in one place.

100's of premium titles.
One news app.

Budget and the Bees

Unexpected Ally: Shingles Vaccine Cuts Heart Attacks Nearly in Half

A growing body of research is reshaping how we think about vaccines, and not just for preventing infections. The shingles vaccine, long recommended for older adults to prevent painful rashes, is now gaining attention for an unexpected benefit: reducing the risk of heart attacks. Recent studies suggest that people who…

The Independent UK

On The Ground | Inside the ‘miracle’ drug rollout that could end Aids

A groundbreaking new drug to prevent HIV infection – the closest the world has to a vaccine – is being rolled out in some of the worst-hit countries in the world. Chief international correspondent Bel Trew reports from Eswatini, southern Africa, where there is hope that the pandemic could be…

The Guardian - US

FDA blocked studies finding Covid and shingles vaccines safe, HHS official says

Serious side-effects from vaccines were rare, scientists found in studies funded by US taxpayer money

Fortune

How the next CDC director could reshape America’s $5.3 trillion health care industry

The CDC’s next leader could influence vaccine policy, hospital care, disease surveillance, and public trust at a pivotal moment for U.S. health care.

The Guardian - US

Who is Nicole Saphier, Trump’s new nominee for US surgeon general?

Trump’s third pick for role is a radiologist and Fox News medical contributor who experts say is ‘almost a lock’

The Mary Sue

RFK Jr.’s latest move to gut vaccine recommendations hit a snag. Now Trump’s team is begging a judge to let them keep dismantling public health

The Trump administration is fighting to keep slashing childhood vaccine recommendations after a federal judge temporarily blocked the move. On April 29, 2026, government lawyers filed an appeal to overturn a March 16 court order that paused Health Secretary Robert F. Kennedy Jr.’s decision to stop broadly recommending vaccines for…

The Independent UK

How the UK quietly became a research powerhouse in the fight against malaria

ON THE GROUND: The UK is driving pioneering malaria research in areas including genetic engineering, vaccines, and medicines. In Tanzania, the scientists involved tell Nick Ferris why research to tackle the disease and save lives is so important, particularly given the foreign aid cuts that are taking place globally

1 … 11 12 13 14

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Wall Street Journal

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.